Truist Financial’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.1M | Sell |
90,782
-8,048
| -8% | -$2.98M | 0.04% | 317 |
|
|
2026
Q1 | $28.9M | Sell |
98,830
-40,057
| -29% | -$13.2M | 0.04% | 340 |
|
|
2025
Q4 | $48.7M | Sell |
138,887
-16,372
| -11% | -$5.53M | 0.06% | 243 |
|
|
2025
Q3 | $50.2M | Sell |
155,259
-57,451
| -27% | -$17.9M | 0.07% | 239 |
|
|
2025
Q2 | $82.7M | Sell |
212,710
-51,058
| -19% | -$20.5M | 0.12% | 160 |
|
|
2025
Q1 | $115M | Buy |
263,768
+14,072
| +6% | +$5.65M | 0.18% | 119 |
|
|
2024
Q4 | $92.1M | Sell |
249,696
-9,394
| -4% | -$3.93M | 0.14% | 136 |
|
|
2024
Q3 | $135M | Sell |
259,090
-290,984
| -53% | -$155M | 0.21% | 92 |
|
|
2024
Q2 | $298M | Buy |
550,074
+5,026
| +0.9% | +$2.66M | 0.45% | 45 |
|
|
2024
Q1 | $283M | Buy |
545,048
+11,584
| +2% | +$5.76M | 0.43% | 49 |
|
|
2023
Q4 | $252M | Sell |
533,464
-48,655
| -8% | -$22.5M | 0.4% | 54 |
|
|
2023
Q3 | $253M | Buy |
582,119
+59,628
| +11% | +$27M | 0.42% | 51 |
|
|
2023
Q2 | $232M | Sell |
522,491
-70,176
| -12% | -$32.4M | 0.39% | 53 |
|
|
2023
Q1 | $273M | Sell |
592,667
-16,594
| -3% | -$7.9M | 0.47% | 43 |
|
|
2022
Q4 | $313M | Sell |
609,261
-5,794
| -0.9% | -$2.94M | 0.55% | 39 |
|
|
2022
Q3 | $279M | Buy |
615,055
+14,599
| +2% | +$6.99M | 0.54% | 37 |
|
|
2022
Q2 | $290M | Sell |
600,456
-19,112
| -3% | -$9.45M | 0.53% | 37 |
|
|
2022
Q1 | $304M | Sell |
619,568
-22,716
| -4% | -$10.4M | 0.48% | 42 |
|
|
2021
Q4 | $298M | Sell |
642,284
-7,810
| -1% | -$3.29M | 0.45% | 52 |
|
|
2021
Q3 | $242M | Sell |
650,094
-10,561
| -2% | -$4.01M | 0.4% | 64 |
|
|
2021
Q2 | $252M | Sell |
660,655
-11,242
| -2% | -$4.3M | 0.41% | 57 |
|
|
2021
Q1 | $241M | Buy |
671,897
+59,555
| +10% | +$19.2M | 0.42% | 59 |
|
|
2020
Q4 | $197M | Buy |
612,342
+6,406
| +1% | +$1.97M | 0.38% | 62 |
|
|
2020
Q3 | $163M | Sell |
605,936
-78,707
| -11% | -$21.2M | 0.36% | 66 |
|
|
2020
Q2 | $180M | Buy |
684,643
+23,982
| +4% | +$6.4M | 0.4% | 58 |
|
|
2020
Q1 | $150M | Buy |
660,661
+116,330
| +21% | +$31.7M | 0.39% | 60 |
|
|
2019
Q4 | $164M | Buy |
544,331
+453,630
| +500% | +$125M | 0.33% | 71 |
|
|
2019
Q3 | $21.8M | Sell |
90,701
-186
| -0.2% | -$51K | 0.37% | 65 |
|
|
2019
Q2 | $25.6M | Sell |
90,887
-1,220
| -1% | -$333K | 0.44% | 56 |
|
|
2019
Q1 | $26.4M | Sell |
92,107
-4,312
| -4% | -$1.25M | 0.47% | 49 |
|
|
2018
Q4 | $25.3M | Sell |
96,419
-2,921
| -3% | -$803K | 0.52% | 44 |
|
|
2018
Q3 | $27.2M | Sell |
99,340
-5,221
| -5% | -$1.36M | 0.49% | 50 |
|
|
2018
Q2 | $24.9M | Sell |
104,561
-3,908
| -4% | -$905K | 0.47% | 50 |
|
|
2018
Q1 | $23.8M | Sell |
108,469
-10,253
| -9% | -$2.41M | 0.45% | 53 |
|
|
2017
Q4 | $26.7M | Sell |
118,722
-4,699
| -4% | -$1M | 0.5% | 47 |
|
|
2017
Q3 | $23.4M | Sell |
123,421
-7,469
| -6% | -$1.42M | 0.45% | 52 |
|
|
2017
Q2 | $24.6M | Sell |
130,890
-10,610
| -7% | -$1.91M | 0.49% | 47 |
|
|
2017
Q1 | $23.4M | Sell |
141,500
-12,022
| -8% | -$1.91M | 0.47% | 48 |
|
|
2016
Q4 | $22.1M | Buy |
153,522
+827
| +0.5% | +$111K | 0.45% | 49 |
|
|
2016
Q3 | $19.1M | Buy |
152,695
+2,696
| +2% | +$348K | 0.39% | 68 |
|
|
2016
Q2 | $19.7M | Buy |
149,999
+46,191
| +44% | +$6.32M | 0.41% | 63 |
|
|
2016
Q1 | $14.4M | Buy |
103,808
+4,372
| +4% | +$584K | 0.37% | 68 |
|
|
2015
Q4 | $13.9M | Buy |
99,436
+1,809
| +2% | +$249K | 0.36% | 72 |
|
|
2015
Q3 | $13.7M | Sell |
97,627
-9,825
| -9% | -$1.48M | 0.36% | 77 |
|
|
2015
Q2 | $17.6M | Sell |
107,452
-14,551
| -12% | -$2.32M | 0.48% | 51 |
|
|
2015
Q1 | $18.8M | Sell |
122,003
-19,682
| -14% | -$2.8M | 0.54% | 43 |
|
|
2014
Q4 | $17.8M | Sell |
141,685
-8,321
| -6% | -$1.03M | 0.52% | 53 |
|
|
2014
Q3 | $17.9M | Sell |
150,006
-3,552
| -2% | -$407K | 0.54% | 50 |
|
|
2014
Q2 | $16.5M | Sell |
153,558
-6,403
| -4% | -$660K | 0.5% | 54 |
|
|
2014
Q1 | $15.9M | Buy |
159,961
+8,906
| +6% | +$805K | 0.5% | 50 |
|
|
2013
Q4 | $14M | Buy |
151,055
+8,946
| +6% | +$795K | 0.45% | 62 |
|
|
2013
Q3 | $11.9M | Buy |
142,109
+10,705
| +8% | +$917K | 0.42% | 62 |
|
|
2013
Q2 | $10.8M | Buy |
+131,404
| New | +$9.83M | 0.4% | 62 |
|
Other funds holding ELV
AACR
HGIM
FI
DC
CF
Truist Financial's ELV Position: Q2 2026 in Review
Truist Financial reduced its Elevance Health (ELV) stake by 8.1% in Q2 2026, selling an estimated $2.98M and leaving 90,782 shares worth $35.1M. The position accounts for 0.04% of the portfolio, ranked #317.
Truist Financial first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $313M in Q4 2022. 574 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Truist Financial held 90,782 shares of Elevance Health worth $35.1M as of Q2 2026.
- Truist Financial sold 8,048 Elevance Health shares in Q2 2026, an estimated $2.98M.
- Elevance Health made up 0.04% of Truist Financial's portfolio in Q2 2026, its #317 holding.
- Truist Financial first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Truist Financial's Elevance Health position peaked at $313M in Q4 2022.
- 574 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.